london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

Anatomic and functional outcome of triamcinolone-assisted 23-gauge vitrectomy in vitreomacular tractionsyndrome

Poster Details

First Author: G.Seymenoglu TURKEY

Co Author(s):    C. Cansız   E. Başer               0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

To evaluate the outcomes of patients with vitreomacular traction syndrome (VMT) treated with triamcinolone acetonid (TA) assisted 23-gauge (23-G) transconjunctival sutureless vitrectomy.

Setting:

Celal Bayar University Hospital Department of Ophthalmology

Methods:

Restrospective, case series. The medical charts of 13 eyes of 13 consecutive patients with VMT who underwent 23-gauge transconjunctival pars plana vitrectomy were reviewed. All patients had at least six-month follow-up. The main outcome parameters were changes in best corrected visual acuity (BCVA) and central macular thickness (CMT) between the baseline and postoperative follow- up examinations performed at the first and sixth months after the surgery.

Results:

The mean follow-up period was 8 (range 6-15) months. The mean preoperative BCVA was 0.77±0.29 (logmar). The BCVA was 0.68±0.28 (logmar) (p = 0.026) at postoperative 1 month, and 0.63±0.23 (logmar) (p = 0.026) at final visit. The mean CMT was 537±22 µm at baseline, which was significantly reduced to 257±12 µm (p=0.005)at 1 month and 223±11 µm at the final follow-up visit (p = 0.005). No postoperative complications were seen such as endophthalmitis, retinal detachment, hypotony, or glaucoma.

Conclusions:

Triamcinolone assisted 23-G transconjunctival sutureless vitrectomy is an effective and safe surgical technique in the management of VMT syndrome. Further studies with large case series are needed.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy